BACKGROUND: Catecholamines increase heart rate by augmenting the cAMP-responsive hyperpolarization-activated cyclic nucleotide-gated channel 4 pacemaker current (I(f)) and by promoting inward Na(+)/Ca(2+) exchanger current (I(NCX)) by a "Ca(2+) clock" mechanism in sinoatrial nodal cells (SANCs). The importance, identity, and function of signals that connect I(f) and Ca(2+) clock mechanisms are uncertain and controversial, but the multifunctional Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is required for physiological heart rate responses to β-adrenergic receptor (β-AR) stimulation. The aim of this study was to measure the contribution of the Ca(2+) clock and CaMKII to cardiac pacing independent of β-AR agonist stimulation. METHODS AND RESULTS: We used the L-type Ca(2+) channel agonist Bay K8644 (BayK) to activate the SANC Ca(2+) clock. BayK and isoproterenol were similarly effective in increasing rates in SANCs and Langendorff-perfused hearts from wild-type control mice. In contrast, SANCs and isolated hearts from mice with CaMKII inhibition by transgenic expression of an inhibitory peptide (AC3-I) were resistant to rate increases by BayK. BayK only activated CaMKII in control SANCs but increased L-type Ca(2+) current (I(Ca)) equally in all SANCs, indicating that increasing I(Ca) was insufficient and suggesting that CaMKII activation was required for heart rate increases by BayK. BayK did not increase I(f) or protein kinase A-dependent phosphorylation of phospholamban (at Ser16), indicating that increased SANC Ca(2+) by BayK did not augment cAMP/protein kinase A signaling at these targets. Late-diastolic intracellular Ca(2+) release and I(NCX) were significantly reduced in AC3-I SANCs, and the response to BayK was eliminated by ryanodine in all groups. CONCLUSIONS: The Ca(2+) clock is capable of supporting physiological fight-or-flight responses, independent of β-AR stimulation or I(f) increases. Complete Ca(2+) clock and β-AR stimulation responses require CaMKII.
BACKGROUND:Catecholamines increase heart rate by augmenting the cAMP-responsive hyperpolarization-activated cyclic nucleotide-gated channel 4 pacemaker current (I(f)) and by promoting inward Na(+)/Ca(2+) exchanger current (I(NCX)) by a "Ca(2+) clock" mechanism in sinoatrial nodal cells (SANCs). The importance, identity, and function of signals that connect I(f) and Ca(2+) clock mechanisms are uncertain and controversial, but the multifunctional Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is required for physiological heart rate responses to β-adrenergic receptor (β-AR) stimulation. The aim of this study was to measure the contribution of the Ca(2+) clock and CaMKII to cardiac pacing independent of β-AR agonist stimulation. METHODS AND RESULTS: We used the L-type Ca(2+) channel agonist Bay K8644 (BayK) to activate the SANC Ca(2+) clock. BayK and isoproterenol were similarly effective in increasing rates in SANCs and Langendorff-perfused hearts from wild-type control mice. In contrast, SANCs and isolated hearts from mice with CaMKII inhibition by transgenic expression of an inhibitory peptide (AC3-I) were resistant to rate increases by BayK. BayK only activated CaMKII in control SANCs but increased L-type Ca(2+) current (I(Ca)) equally in all SANCs, indicating that increasing I(Ca) was insufficient and suggesting that CaMKII activation was required for heart rate increases by BayK. BayK did not increase I(f) or protein kinase A-dependent phosphorylation of phospholamban (at Ser16), indicating that increased SANC Ca(2+) by BayK did not augment cAMP/protein kinase A signaling at these targets. Late-diastolic intracellular Ca(2+) release and I(NCX) were significantly reduced in AC3-I SANCs, and the response to BayK was eliminated by ryanodine in all groups. CONCLUSIONS: The Ca(2+) clock is capable of supporting physiological fight-or-flight responses, independent of β-AR stimulation or I(f) increases. Complete Ca(2+) clock and β-AR stimulation responses require CaMKII.
Authors: Andrew M Bellinger; Steven Reiken; Christian Carlson; Marco Mongillo; Xiaoping Liu; Lisa Rothman; Stefan Matecki; Alain Lacampagne; Andrew R Marks Journal: Nat Med Date: 2009-02-08 Impact factor: 53.440
Authors: Yuejin Wu; Zhan Gao; Biyi Chen; Olha M Koval; Madhu V Singh; Xiaoqun Guan; Thomas J Hund; William Kutschke; Satyam Sarma; Isabella M Grumbach; Xander H T Wehrens; Peter J Mohler; Long-Sheng Song; Mark E Anderson Journal: Proc Natl Acad Sci U S A Date: 2009-03-10 Impact factor: 11.205
Authors: Andriy E Belevych; Hsiang-Ting Ho; Ingrid M Bonilla; Radmila Terentyeva; Karsten E Schober; Dmitry Terentyev; Cynthia A Carnes; Sándor Györke Journal: Basic Res Cardiol Date: 2017-06-13 Impact factor: 17.165
Authors: Yue Li; Syevda Sirenko; Daniel R Riordon; Dongmei Yang; Harold Spurgeon; Edward G Lakatta; Tatiana M Vinogradova Journal: Am J Physiol Heart Circ Physiol Date: 2016-07-08 Impact factor: 4.733
Authors: Sean DeGrande; Derek Nixon; Olha Koval; Jerald W Curran; Patrick Wright; Qiongling Wang; Farshid Kashef; David Chiang; Na Li; Xander H T Wehrens; Mark E Anderson; Thomas J Hund; Peter J Mohler Journal: Heart Rhythm Date: 2012-08-28 Impact factor: 6.343
Authors: Jie Liu; Syevda Sirenko; Magdalena Juhaszova; Bruce Ziman; Veena Shetty; Silvia Rain; Shweta Shukla; Harold A Spurgeon; Tatiana M Vinogradova; Victor A Maltsev; Edward G Lakatta Journal: J Mol Cell Cardiol Date: 2011-08-04 Impact factor: 5.000
Authors: Anand M Prasad; Daniel W Nuno; Olha M Koval; Pimonrat Ketsawatsomkron; Weiwei Li; Hui Li; Fred Y Shen; Mei-ling A Joiner; William Kutschke; Robert M Weiss; Curt D Sigmund; Mark E Anderson; Kathryn G Lamping; Isabella M Grumbach Journal: Hypertension Date: 2013-06-10 Impact factor: 10.190
Authors: Zhan Gao; Tyler P Rasmussen; Yue Li; William Kutschke; Olha M Koval; Yiming Wu; Yuejin Wu; Duane D Hall; Mei-ling A Joiner; Xiang-Qiong Wu; Paari D Swaminathan; Anil Purohit; Kathy Zimmerman; Robert M Weiss; Kenneth D Philipson; Long-sheng Song; Thomas J Hund; Mark E Anderson Journal: Circ Res Date: 2012-11-27 Impact factor: 17.367
Authors: Klitos Konstantinidis; Vassilios J Bezzerides; Lo Lai; Holly M Isbell; An-Chi Wei; Yuejin Wu; Meera C Viswanathan; Ian D Blum; Jonathan M Granger; Danielle Heims-Waldron; Donghui Zhang; Elizabeth D Luczak; Kevin R Murphy; Fujian Lu; Daniel H Gratz; Bruno Manta; Qiang Wang; Qinchuan Wang; Alex L Kolodkin; Vadim N Gladyshev; Thomas J Hund; William T Pu; Mark N Wu; Anthony Cammarato; Mario A Bianchet; Madeline A Shea; Rodney L Levine; Mark E Anderson Journal: J Clin Invest Date: 2020-09-01 Impact factor: 14.808